Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases Positive Results for Phase IIb Study
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases Positive Results for Phase IIb Study
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases Positive Results for Phase IIb Study
Submitted by
admin
on February 25, 2015 - 10:16am
Source:
Streetwise Report
News Tags:
Teva Pharmaceuticals
TEV-48125
migraine
Headline:
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Releases Positive Results for Phase IIb Study
Do Not Allow Advertisers to Use My Personal information
